Pyrroloquinoline quinone (PQQ)

DIETARY_SUPPLEMENT2 trials

Sponsors

University of Oklahoma, Tianjin Anding Hospital

Conditions

Cognitive SymptomsMaternal ObesityNegative SymptomsSchizophrenia

Early Phase 1

Evaluating Pyrroloquinoline Quinone (PQQ) for Improving Obese Pregnancy Outcomes

WithdrawnNCT06245083

University of OklahomaMaternal Obesity

Start: 2024-12-31End: 2025-08-31Updated: 2025-02-13

Unknown Phase

PQQ for Cognitive and Negative Symptoms

Not yet recruitingNCT07393464

Tianjin Anding HospitalCognitive Symptoms, Negative Symptoms, Schizophrenia

Start: 2026-02-15End: 2028-04-15Target: 70Updated: 2026-02-10